ATE109981T1 - Therapeutische mittel. - Google Patents

Therapeutische mittel.

Info

Publication number
ATE109981T1
ATE109981T1 AT90904349T AT90904349T ATE109981T1 AT E109981 T1 ATE109981 T1 AT E109981T1 AT 90904349 T AT90904349 T AT 90904349T AT 90904349 T AT90904349 T AT 90904349T AT E109981 T1 ATE109981 T1 AT E109981T1
Authority
AT
Austria
Prior art keywords
formula
compound
ace
inhibitor
methyl
Prior art date
Application number
AT90904349T
Other languages
English (en)
Inventor
Patrick Coleman O'connor
Charles Leon-Marie Defesche
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of ATE109981T1 publication Critical patent/ATE109981T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT90904349T 1989-03-15 1990-03-12 Therapeutische mittel. ATE109981T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32421389A 1989-03-15 1989-03-15

Publications (1)

Publication Number Publication Date
ATE109981T1 true ATE109981T1 (de) 1994-09-15

Family

ID=23262607

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90904349T ATE109981T1 (de) 1989-03-15 1990-03-12 Therapeutische mittel.

Country Status (13)

Country Link
EP (1) EP0527720B1 (de)
JP (1) JPH04503806A (de)
KR (1) KR920700642A (de)
AT (1) ATE109981T1 (de)
AU (1) AU640128B2 (de)
CA (1) CA2049980A1 (de)
DE (1) DE69011692T2 (de)
DK (1) DK0527720T3 (de)
ES (1) ES2057542T3 (de)
IE (1) IE65902B1 (de)
IL (1) IL93744A (de)
WO (1) WO1990010445A1 (de)
ZA (1) ZA901945B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2345192A (en) * 1992-07-21 1994-02-14 Boots Company Plc, The Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat

Also Published As

Publication number Publication date
IE900818L (en) 1990-09-15
CA2049980A1 (en) 1990-09-16
WO1990010445A1 (en) 1990-09-20
DK0527720T3 (da) 1994-12-05
IL93744A (en) 1995-06-29
DE69011692T2 (de) 1994-12-01
JPH04503806A (ja) 1992-07-09
AU5261690A (en) 1990-10-09
EP0527720B1 (de) 1994-08-17
IE65902B1 (en) 1995-11-29
DE69011692D1 (de) 1994-09-22
ZA901945B (en) 1991-01-30
EP0527720A1 (de) 1993-02-24
ES2057542T3 (es) 1994-10-16
IL93744A0 (en) 1990-12-23
AU640128B2 (en) 1993-08-19
KR920700642A (ko) 1992-08-10

Similar Documents

Publication Publication Date Title
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
RU94026283A (ru) Фармацевтическое соединение
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
ATE109981T1 (de) Therapeutische mittel.
GB1375806A (de)
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
GEP20012366B (en) Thienyl-, Furil-, Pyrrolyl- and Biphenyl-Sulfonamides, Their Derivatives, Their Use in Medicinal Purposes, Pharmaceutical Composition Containing the Same and Method for Treatment

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee